New Rosacea Foam Treatment Approved by FDA

Article

Finacea Foam showed a greater reduction in the average nominal change of inflammatory lesion count.

Finacea Foam showed a greater reduction in the average nominal change of inflammatory lesion count.

The FDA today approved azelaic acid foam 15% (Finacea) to treat inflammatory papules and pustules of mild to moderate rosacea.

Rosacea is a skin disease that often creates papules and pustules on the nose, cheeks, chin, and forehead. Clinical trials found Finacea Foam to be more effective than foam without acelaic acid to treat papulopustular rosacea.

The intervention treatment showed a greater reduction in the average nominal change of inflammatory lesion count from baseline after 12 weeks of twice-daily treatment. Finacea Foam also had a greater Investigator’s Global Assessment success rate compared with the control treatment.

The 2 clinical trials involved 1362 subjects, aged 19 to 92 years, with a mean lesion count of 21.3.

“With the FDA’s approval of Finacea Foam, we can now offer patients suffering from rosacea in the United States a new treatment option,” John O’Mullane, head of Innovation, Research, & Development at Bayer HealthCare’s Consumer Care division, said in a press release. “This demonstrates Bayer’s continued commitment to delivering innovation that meets the preferences and needs of patients with mild to moderate rosacea.”

Patients may experience adverse reactions such as local application site pain, pruritus, dryness, and erythema. Bayer HealthCare’s product is expected to become available in September 2015.

Related Videos
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.